In the cardiovascular field, tocilizumab significantly reduced the risk of MI by 88% and major adverse cardiovascular events by 59% in a nationwide cohort study of 1,584 RA patients unresponsive to TNF- inhibitors [344]
Reflecting the fact that GLP-1 receptors have been found to be substantially more abundant in the human lung than other organs, GLP-1 drugs are now also being explored for the treatment of acute and chronic pulmonary disease
In addition to the improvement in HbA1c and glucose profile, tirzepatide has also demonstrated to improve insulin resistance, as assessed by HOMA-IR
Medicare recipients beginning in 2026
The right decision depends on your specific health circumstances, your comfort level with compounded medications, your financial situation, and the guidance of qualified healthcare professionals who have reviewed your individual medical history
It organizes progress data, but medication decisions and clinical interpretation belong with your healthcare professional
.png?w=1536&max-h=2752&fit=crop&auto=format)
